<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Oncol</journal-id><journal-id journal-id-type="iso-abbrev">J. Clin. Oncol</journal-id><journal-id journal-id-type="pmc-domain-id">660</journal-id><journal-id journal-id-type="pmc-domain">jco</journal-id><journal-id journal-id-type="publisher-id">JCO</journal-id><journal-title-group><journal-title>Journal of Clinical Oncology</journal-title></journal-title-group><issn pub-type="ppub">0732-183X</issn><issn pub-type="epub">1527-7755</issn><publisher><publisher-name>American Society of Clinical Oncology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7430217</article-id><article-id pub-id-type="pmcid-ver">PMC7430217.1</article-id><article-id pub-id-type="pmcaid">7430217</article-id><article-id pub-id-type="pmcaiid">7430217</article-id><article-id pub-id-type="pmid">32496904</article-id><article-id pub-id-type="doi">10.1200/JCO.19.02760</article-id><article-id pub-id-type="publisher-id">1902760</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="subjects"><compound-subject><compound-subject-part content-type="code">[EPID6]</compound-subject-part><compound-subject-part content-type="label">Genetic Epidemiology</compound-subject-part></compound-subject><compound-subject><compound-subject-part content-type="code">[PEDI24]</compound-subject-part><compound-subject-part content-type="label">Long Term Survival &amp; Late Effects</compound-subject-part></compound-subject><compound-subject><compound-subject-part content-type="code">[PCS46]</compound-subject-part><compound-subject-part content-type="label">Pediatric Cancer Specialty: Long Term Survival &amp; Late Effects - Second Cancer</compound-subject-part></compound-subject></subj-group><subj-group subj-group-type="heading"><subject>ORIGINAL REPORTS</subject><subj-group><subject>Pediatric Oncology</subject></subj-group></subj-group></article-categories><title-group><article-title>Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer</article-title><alt-title alt-title-type="short">DNA Repair Gene Germline Mutations and Risk of Second Cancers</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Qin</surname><given-names initials="N">Na</given-names></name><degrees>PhD, MD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhaoming</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Q">Qi</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Song</surname><given-names initials="N">Nan</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wilson</surname><given-names initials="CL">Carmen L.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ehrhardt</surname><given-names initials="MJ">Matthew J.</given-names></name><degrees>MD, MS</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="K">Kyla</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Easton</surname><given-names initials="J">John</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mulder</surname><given-names initials="H">Heather</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kennetz</surname><given-names initials="D">Dennis</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Edmonson</surname><given-names initials="MN">Michael N.</given-names></name><degrees>BA</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rusch</surname><given-names initials="MC">Michael C.</given-names></name><degrees>BA</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Downing</surname><given-names initials="JR">James R.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hudson</surname><given-names initials="MM">Melissa M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nichols</surname><given-names initials="KE">Kim E.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jinghui</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Robison</surname><given-names initials="LL">Leslie L.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yasui</surname><given-names initials="Y">Yutaka</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label><sup>1</sup></label>Department of Epidemiology and Cancer Control, St Jude Children&#8217;s Research Hospital, Memphis, TN</aff><aff id="aff2"><label><sup>2</sup></label>Department of Computational Biology, St Jude Children&#8217;s Research Hospital, Memphis, TN</aff><aff id="aff3"><label><sup>3</sup></label>School of Public Health, University of Alberta, Edmonton, Alberta, Canada</aff><aff id="aff4"><label><sup>4</sup></label>Department of Oncology, St Jude Children&#8217;s Research Hospital, Memphis, TN</aff><aff id="aff5"><label><sup>5</sup></label>Department of Pathology, St Jude Children&#8217;s Research Hospital, Memphis, TN</aff></contrib-group><author-notes><corresp id="cor1">Zhaoming Wang, PhD, Department of Epidemiology and Cancer Control, St Jude Children&#8217;s Research Hospital, 262 Danny Thomas Pl, MS 735, Memphis, TN 38105; e-mail: <email>Zhaoming.Wang@stjude.org</email>.</corresp><fn id="afn1" fn-type="equal" specific-use="equal"><p>N.Q., Z.W., and Q.L. contributed equally to this work. Y.Y., L.L.R., and J.Z. contributed equally as co-senior authors.</p></fn></author-notes><pub-date pub-type="ppub"><day>20</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>4</day><month>6</month><year>2020</year></pub-date><volume>38</volume><issue>24</issue><issue-id pub-id-type="pmc-issue-id">363443</issue-id><fpage>2728</fpage><lpage>2740</lpage><history><date date-type="accepted"><day>15</day><month>4</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>20</day><month>08</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>20</day><month>08</month><year>2021</year></date></event><event event-type="pmc-released-under-embargo"><date><day>19</day><month>08</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-20 14:25:26.857"><day>20</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2020 by American Society of Clinical Oncology</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Society of Clinical Oncology</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JCO.19.02760.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:title="pdf" xlink:href="JCO.19.02760.pdf"/><abstract><sec><title>PURPOSE</title><p>To investigate cancer treatment plus pathogenic germline mutations (PGMs) in DNA repair genes (DRGs) for identification of childhood cancer survivors at increased risk of subsequent neoplasms (SNs).</p></sec><sec><title>METHODS</title><p>Whole-genome sequencing was performed on blood-derived DNA from survivors in the St Jude Lifetime Cohort. PGMs were evaluated in 127 genes from 6 major DNA repair pathways. Cumulative doses of chemotherapy and body region&#8211;specific radiotherapy (RT) were abstracted from medical records. Relative rates (RRs) and 95% CIs of SNs by mutation status were estimated using multivariable piecewise exponential models.</p></sec><sec><title>RESULTS</title><p>Of 4,402 survivors, 495 (11.2%) developed 1,269 SNs. We identified 538 PGMs in 98 DRGs (<italic toggle="yes">POLG</italic>, <italic toggle="yes">MUTYH</italic>, <italic toggle="yes">ERCC2</italic>, and <italic toggle="yes">BRCA2</italic>, among others) in 508 (11.5%) survivors. Mutations in homologous recombination (HR) genes were significantly associated with an increased rate of subsequent female breast cancer (RR, 3.7; 95% CI, 1.8 to 7.7), especially among survivors with chest RT &#8805; 20 Gy (RR, 4.4; 95% CI, 1.6 to 12.4), or with a cumulative dose of anthracyclines in the second or third tertile (RR, 4.4; 95% CI, 1.7 to 11.4). Mutations in HR genes were also associated with an increased rate of subsequent sarcoma among those who received alkylating agent doses in the third tertile (RR, 14.9; 95% CI, 4.0 to 38.0). Mutations in nucleotide excision repair genes were associated with subsequent thyroid cancer for those treated with neck RT &#8805; 30 Gy (RR, 12.9; 95% CI, 1.6 to 46.6) with marginal statistical significance.</p></sec><sec><title>CONCLUSION</title><p>Our study provides novel insights regarding the contribution of genetics, in combination with known treatment-related risks, for the development of SNs. These findings have the potential to facilitate identification of high-risk survivors who may benefit from genetic counseling and/or testing of DRGs, which may further inform personalized cancer surveillance and prevention strategies.</p></sec></abstract><counts><fig-count count="3"/><table-count count="3"/><equation-count count="0"/><ref-count count="33"/><page-count count="14"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name> SJS Export </meta-name><meta-value>v1</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>